A carregar...

Bapineuzumab

IMPORTANCE OF THE FIELD: Alzheimer’s disease is the leading cause of dementia in the elderly, and there is no disease-modifying therapy yet available. Immunotherapy directed against the β-amyloid peptide may be capable of slowing the rate of disease progression. Bapineuzumab, an anti–β-amyloid monoc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kerchner, Geoffrey A., Boxer, Adam L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3000430/
https://ncbi.nlm.nih.gov/pubmed/20497044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2010.493872
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!